Please login to the form below

Not currently logged in
Email:
Password:

Palynziq

This page shows the latest Palynziq news and features for those working in and with pharma, biotech and healthcare.

BioMarin ticks over in Q2 ahead of gene therapy filing

BioMarin ticks over in Q2 ahead of gene therapy filing

our late stage clinical programmes, and higher marketing and sales expenses in support of the commercial launches of Palynziq and Brineura”. ... Analysts at William Blair say they will expect to see the impact of EU approval for Palynziq in Q3, which

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics